Inpefa Dosage
Generic name: sotagliflozin 200mg
Dosage form: tablet
Drug class: SGLT-2 inhibitors
Medically reviewed by Drugs.com. Last updated on Jan 15, 2024.
Prior to Initiation of INPEFA
Assess volume status and, if necessary, correct volume depletion prior to initiation of INPEFA.
Assess renal function prior to initiation of INPEFA and then as clinically indicated.
For patients with decompensated heart failure, dosing may begin as soon as the patient is hemodynamically stable, including during hospitalization or urgent outpatient treatment or immediately upon discharge.
Recommended Dosage
The recommended starting dose of INPEFA is 200 mg orally once daily not more than one hour before the first meal of the day.
Up-titrate after at least 2 weeks to 400 mg orally once daily as tolerated. Down-titrate to 200 mg as necessary.
Swallow tablets whole. Do not cut, crush, or chew tablets.
If a dose of INPEFA is missed by more than 6 hours, take the next dose as prescribed the next day.
More about Inpefa (sotagliflozin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- During pregnancy
- FDA approval history
- Drug class: SGLT-2 inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
See also:
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Rybelsus
Rybelsus tablets are used to improve blood sugar control in adults with type 2 diabetes, and may ...
Mounjaro
Mounjaro is used for type 2 diabetes to help lower blood sugar levels. Mounjaro has also been shown ...
Jardiance
Jardiance (empagliflozin) is used to treat type 2 diabetes, chronic kidney disease and reduce the ...
Farxiga
Farxiga (dapagliflozin) is an oral prescription medication that may be given to certain adults with ...
Lasix
Lasix is a loop diuretic used to treat fluid retention from heart, liver, or kidney conditions, and ...
Wegovy
Wegovy (semaglutide) an FDA-approved weekly injection for weight loss and to reduce heart risks ...
Kerendia
Kerendia is used for the treatment of patients with chronic kidney disease (CKD) associated with ...
Dapagliflozin
Dapagliflozin (Farxiga) is an SGLT2 inhibitor that is mainly used alongside diet and exercise to ...
Empagliflozin
Empagliflozin is used for cardiovascular risk reduction, chronic kidney disease, heart failure ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.